Ignite Creation Date:
2025-12-24 @ 2:52 PM
Ignite Modification Date:
2026-02-26 @ 7:23 PM
Study NCT ID:
NCT00087659
Status:
COMPLETED
Last Update Posted:
2009-11-23
First Post:
2004-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy
Sponsor:
Novartis Pharmaceuticals
Organization:
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2009-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being conducted to compare the effect of an investigational drug versus placebo on bone loss in men with prostate cancer who are receiving Androgen Deprivation Therapy (ADT). The study drug or placebo will be administered every three months of four treatments in one year.
In order to participate, male patients 18 years and older must be consecutive veterans from participating Veterans Administration Medical Centers.
In order to participate, male patients 18 years and older must be consecutive veterans from participating Veterans Administration Medical Centers.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| US63, US72 H014 | None | None | View |